Medicine
Norepinephrine 4 mg/4 mL injection
Norepinephrine 4 mg/4 mL injection is a generic prescription medicine for intravenous use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Store in original carton until time of…
Key facts
- Active ingredient (INN)
- Norepinephrine
- Brand
- Sold under the generic name
- Strength
- 4 mg/4 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 4 mL, 25 vials of 4 mL, 4 mL and 22 more
- Manufacturers
- Anthea PharmaIndiaBioconIndiaCamber PharmaceuticalsIndiaCaplin SterilesIndiaGland PharmaIndiaNovadoz PharmaceuticalsIndiaHealthFirstBE PharmaceuticalsFresenius KabiNorthStar Rx
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Store in original carton until time of administration to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA03 Norepinephrine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 August 2018
- Identifiers
- RxCUI 242969DailyMed set ID 728734e7-1684-4b37-980c-f1dfd408b436, cc9ecec5-3bd7-4132-9745-7666bac8ceac, c90d875c-8e6e-284e-e053-2a95a90a334f +20NDC 0781-3755, 25021-316, 51662-1528 +20Application ANDA211359, ANDA214323, ANDA203662 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 4 mL in 1 vial | 83854-017-10 | Anthea PharmaIndia | 25 November 2025 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 70377-121-12 | BioconIndia | 1 July 2025 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 31722-372-32 | Camber PharmaceuticalsIndia | 31 January 2025 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 65145-133-10 | Caplin SterilesIndia | 28 September 2024 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 68083-437-10 | Gland PharmaIndia | 12 May 2021 |
| 10 vial in 1 carton / 4 mL in 1 vial | 72205-241-07 | Novadoz PharmaceuticalsIndia | 11 December 2025 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 63323-940-04 | Fresenius Kabi | 1 March 2021 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 65219-140-04 | Fresenius Kabi | 1 March 2021 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 43066-997-10 | Baxter Healthcare | 6 May 2021 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 71839-143-10 | BE Pharmaceuticals | 30 December 2023 |
| 25 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 71839-143-25 | BE Pharmaceuticals | 30 December 2023 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 51991-983-17 | Breckenridge Pharmaceutical | 1 July 2021 |
| 10 vial in 1 carton / 4 mL in 1 vial | 0143-9318-10 | Hikma Pharmaceuticals | 1 August 2018 |
| 10 vial, single-use in 1 carton / 4 mL in 1 vial, single-use | 71288-439-05 | Meitheal Pharmaceuticals | 1 December 2024 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 67457-852-04 | Mylan Institutional | 15 October 2018 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 64980-630-41 | Rising Pharma Holdings | 1 November 2024 |
| 10 vial in 1 carton / 4 mL in 1 vial | 25021-316-04 | Sagent Pharmaceuticals | 1 July 2021 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 0781-3755-95 | Sandoz | 23 April 2019 |
| 4 mL in 1 vial, single-dose | 51662-1315-1 | HealthFirst | 18 October 2018 |
| 4 mL in 1 vial | 51662-1528-1 | HealthFirst | 8 August 2021 |
| 10 pouch in 1 case / 1 vial in 1 pouch / 4 mL in 1 vial | 51662-1528-3 | HealthFirst | 10 July 2022 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 72603-180-10 | NorthStar Rx | 1 December 2023 |
| 10 vial, single-use in 1 carton / 4 mL in 1 vial, single-use | 72603-806-10 | Northstar Rx | 30 October 2026 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 83634-307-04 | Avenacy | 1 February 2026 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 72572-481-10 | Civica | 12 March 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 July 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Norepinephrine 4 mg/4 mL injection.
Other strengths and forms of Norepinephrine
Clinical summary
Norepinephrine is a catecholamine indicated to raise blood pressure in adult patients with severe, acute hypotension. It is available as injection for intravenous use. MedsAcross supplies Norepinephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NorepinephrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LEVOPHED prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Norepinephrine 4 mg/4 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.